About Index Trending news
Analyze
Pricing
Forbion Capital Partners

Forbion Capital Partners

Work at Forbion Capital Partners? Add yourself to this profile

Forbion Capital Partners

Elsewhere

Contributors to this profile

Alexa global traffic share

07 Feb 2017

Prexton Therapeutics, participated by Ysios Capital, Series B financing round raises € 29 millions to advance its novel Parkinson’s therapeutic.es

capital-riesgo
+1
05 Jan 2017
£23,000,000
Venture capital (Series B)
Added by

NeRRE Therapeutics picks up Series B funds

PE Hub
+2
06 Sep 2016
€15,000,000
Venture capital (Series A)
Sunstone Capital, MP Healthcare Venture Management, NRW.BANK, +3
Added by

Rigontec Raises €15M in Third Closing of Series A Funding

FinSMEs
15 Jun 2016
€22,000,000
Venture capital (Series B)
EMBL Ventures, Forbion Capital Partners, Edmond de Rothschild Investment Partners, +2

Allecra Therapeutics Announces €22 Million Series B Financing

prnewswire
+1
16 Feb 2016
$15,000,000
Venture capital (Series B)
Added by

Akarna Therapeutics Closes $15M Series B Financing

FinSMEs
07 Jan 2016
$60,000,000
Venture capital (Series B)
Tiger Management Corporation, Qiagen, Arcus Ventures, +5

Exosome Diagnostics Completes $60 Million Series B Financing

businesswire
+2
02 Sep 2015
$17,600,000
Venture capital (Series B)
Tiger Management Corporation, CD-Venture, Arcus Ventures, +2
Added by

Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing

BioPortfolio
11 Mar 2014
$27,000,000
Venture capital (Series B)
b-to-v Partners AG, Qiagen, Arcus Ventures, +2
Added by

Exosome Diagnostics raises USD 27m in Series B Financing Partners AG

b-to-v
+1
25 Jul 2012
20 Apr 2011
04 Feb 2011
$48,268,413
Venture capital (Series B)
Advent Venture Partners, Auriga Partners, Crédit Agricole Private Equity, +5
11 May 2010
$20,000,000
Venture capital (Series A)
Added by
12 Mar 2010
$35,000,000
Venture capital (Series B)
30 Mar 2009
$40,000,000
Venture capital (Series F)
Crédit Agricole Private Equity, Scottish Equity Partners (SEP), New Science Ventures, +4